Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has David D. Stenehjem's publication output changed over time?
ScholarIQpublication output · 2008–2021
Output grew100% over the shown period — from 1 works in 2008 to 2 in 2021.
1
1
1
1
1
1
1
1
1
2
2008200920122013201520172018201920202021
What are the most-cited papers on David D. Stenehjem?
ScholarIQmost cited works
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Gary H. Lyman, Marc Carrier, Cihan Ay, Marcello Di Nisio, Lisa K. Hicks, Alok A. Khorana, Andrew D. Leavitt, Agnes Lee, Fergus Macbeth, Rebecca L. Morgan, Simon Noble, Elizabeth A. Sexton, David D. Stenehjem, Wojtek Wiercioch, Lara A Kahale, Pablo Alonso‐Coello
Blood Advances. 2021868 CitationsOPEN ACCESS
Diagnosis and treatment of cancer‐related anemia
Jeffrey A. Gilreath, David D. Stenehjem, George M. Rodgers
American Journal of Hematology. 2013247 Citations
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer
David D. Stenehjem, Dao Tran, Michael Nkrumah, Shilpa Gupta
S120324992. 2018154 CitationsOPEN ACCESS
Real-world outcomes of immunotherapy–based regimens in first-line advanced non-small cell lung cancer
David Waterhouse, Jenny Lam, Keith A. Betts, Lei Yin, Sophie Gao, Yong Yuan, John Hartman, Sumati Rao, Solomon J. Lubinga, David D. Stenehjem
Lung Cancer. 2021142 CitationsOPEN ACCESS
Circulating immune cell phenotype dynamics reflect the strength of tumor–immune cell interactions in patients during immunotherapy
Jason I. Griffiths, Pierre Wallet, Lance Pflieger, David D. Stenehjem, Xuan Liu, Patrick A. Cosgrove, Neena A. Leggett, Jasmine A. McQuerry, Gajendra Shrestha, Maura Rossetti, Gemalene Sunga, Philip J. Moos, Frederick R. Adler, Jeffrey T. Chang, Sunil Sharma, Andrea H. Bild
Proceedings of the National Academy of Sciences. 2020105 CitationsOPEN ACCESS
Related on ScholarIQ
University of Minnesota
Institution
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Paper
Diagnosis and treatment of cancer‐related anemia
Paper
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer
Paper
Real-world outcomes of immunotherapy–based regimens in first-line advanced non-small cell lung cancer
Paper
Circulating immune cell phenotype dynamics reflect the strength of tumor–immune cell interactions in patients during immunotherapy
Paper